Literature DB >> 2544698

Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer.

N Tonami1, N Shuke, K Yokoyama, H Seki, T Takayama, S Kinuya, K Nakajima, T Aburano, K Hisada, Y Watanabe.   

Abstract

Thallium-201 SPECT was performed in 30 patients with suspected lung cancer. Both early and delayed scans demonstrated abnormal accumulation in all of 23 malignant pulmonary lesions including 21 lung cancer and in two of seven benign conditions. There were significant differences in delayed ratio (uptake ratio of the lesion to the normal lung on delayed scan) and retention index (degree of retention in the lesion) between lung cancer and benign conditions, respectively (p less than 0.01, p less than 0.05). The delayed ratio and retention index revealed that adenocarcinoma showed higher 201Tl accumulation than squamous cell carcinoma and small cell carcinoma (p less than 0.05) and 201Tl clearance in squamous cell carcinoma was faster than in the other two (p less than 0.05). Mediastinal involvement was detected in five of seven patients on delayed scans. The smallest lesion depicted was 1.5 cm in diameter. Two false negatives had small metastases less than 1.0 cm in diameter. This method seems to be useful to detect lung cancer, to differentiate malignant from benign lesions, and to evaluate mediastinal involvement from lung cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544698

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.

Authors:  Jong-Kang Lee; Yeu-Sheng Tyan; Wen-Sheng Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

2.  Single photon emission computed tomography using 201Tl chloride in pulmonary nodules: comparison with 67Ga citrate and 99mTc-labeled hexamethylpropyleneamine-oxime.

Authors:  K Itoh; H Takekawa; E Tsukamoto; K Nagao; K Nakada; S Abe; Y Kawakami; M Furudate
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

3.  Early and delayed thallium-201 scintigraphy in thyroid nodules: the relationship between early thallium-201 uptake and perfusion.

Authors:  E Derebek; S Biberoglu; O Kut; S Yesil; S Saydam; M Yilmaz; O Yenici; E Igci; O Gokce; S Canda; A Büyükgebiz; A S Dogan; H Durak
Journal:  Eur J Nucl Med       Date:  1996-05

4.  Intense and prolonged Tl-201 accumulation in a slow growing bronchioloalveolar carcinoma.

Authors:  S Kinuya; S Takahashi; M Saito; Y Tofuku; T Michigishi; N Tonami
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

5.  Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer.

Authors:  S Matsuno; M Tanabe; Y Kawasaki; K Satoh; A E Urrutia; M Ohkawa; M Maeda
Journal:  Eur J Nucl Med       Date:  1992

6.  Technetium-99m tetrofosmin uptake in lung cancer: comparison with thallium-201.

Authors:  I Matsunari; S Kinuya; T Nishikawa; M Matoba; K Murakita; M Ohguchi; K Ichiyanagi; J Taki; N Tonami; K Hisada
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

7.  201TL SPECT for evaluating head and neck cancer.

Authors:  S Nagamachi; H Hoshi; S Jinnouchi; T Ohnishi; L G Flores; S Futami; H Nakahara; K Watanabe
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 8.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

9.  Evaluation of Tl-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors.

Authors:  R Namba; I Narabayashi; R Matsui; K Sueyoshi; Y Nakata; K Tabuchi; T Komori
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

10.  Limits of Tumor Detectability in Nuclear Medicine and PET.

Authors:  Yusuf Emre Erdi
Journal:  Mol Imaging Radionucl Ther       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.